Treatment
-
Tomorrow’s TrialsNew tools are being integrated into the research process to ease patients' access to clinical trials and improve their experience.
by Bradley Jones
-
Forward Look
What’s Next?Off-the-shelf equivalents to CAR-T cell therapy are emerging.
by Bradley Jones
-
From the Editor-in-Chief
Improving Health After TreatmentThe U.S. health care system must adapt to the needs of cancer survivors.
by William G. Nelson, MD, PhD
-
Getting a Read on CancerCancer patients are increasingly receiving treatments guided by the molecular characteristics of their cancer cells. But patients may have unequal access to testing and targeted therapies.
by Kate Yandell
-
When a Top-Ranked Cancer Center Comes to a Hospital Near YouResearch shows prominent cancer hospitals have different surgical outcomes than their affiliates.
by Marci A. Landsmann
-
Forward Look
Targeted ChemotherapyComputational and molecular biologist Sourav Bandyopadhyay discusses new ways to think about chemotherapy.
by Sue Rochman
-
The Week in Cancer News: May 3Prospective CRISPR application targets cancer directly, HER2 testing accessibility poor in many countries.
by Bradley Jones
-
From the Editor-in-Chief
CAR-T Cells: ‘Bionic’ Immune Cells for Treating CancerT cells are being rebuilt to kill cancer cells.
by William G. Nelson, MD, PhD
-
PARP Inhibitors in Pancreatic CancerDrugs that target DNA repair enzymes may provide alternatives to long-term chemotherapy for some patients with pancreatic cancer.
by Kate Yandell
-
Forward Look
Cloning CancerScientists are testing treatments on lab-grown tumor tissue.
by Chris Palmer
